Ken Griffin Inhibrx Biosciences Inc.

Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$32.6

Avg closing price
Price range
Ken Griffin Portfolio Stock Details (INBX)

11 Ken Griffin Inhibrx Biosciences Trades

The first Inhibrx Biosciences trade was made in Q4 2021. Since then Ken Griffin bought shares seven more times and sold shares on three occasions. The investor sold all their shares in Q2 2024 and doesn't own any shares in Inhibrx Biosciences anymore.

Avg closing price
Price range
Sold -1.2 Million shares Q2 2024
Avg closing price $28.22
Price range $14.06 - $35.08
Increased shares by 372.6% (+949 Thousand shares) Q1 2024
Avg closing price $36.47
Price range $32.76 - $39.56
Increased shares by 5.0% (+12 Thousand shares) Q4 2023
Avg closing price $21.43
Price range $14.50 - $38.00
Increased shares by 263.4% (+176 Thousand shares) Q3 2023
Avg closing price $20.92
Price range $15.75 - $26.31
Increased shares by 241.2% (+47.2 Thousand shares) Q2 2023
Avg closing price $23.35
Price range $16.96 - $27.82
Sold 66.8% shares (-39.3 Thousand shares) Q1 2023
Avg closing price $23.26
Price range $18.45 - $27.14
Increased shares by 9.1% (+4.89 Thousand shares) Q4 2022
Avg closing price $29.39
Price range $20.18 - $33.33
Increased shares by 21.3% (+9.48 Thousand shares) Q3 2022
Avg closing price $18.03
Price range $11.58 - $24.73
Sold 68.5% shares (-96.9 Thousand shares) Q2 2022
Avg closing price $14.71
Price range $8.52 - $25.26
Increased shares by 1360.4% (+132 Thousand shares) Q1 2022
Avg closing price $25.53
Price range $19.89 - $43.18
New holding (+9.69 Thousand shares) Q4 2021
Avg closing price $39.99
Price range $26.75 - $46.02
Never miss a trade

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!

To improve your user experience we use cookies.